Yahoo Web Search

Search results

1. • Texas Company's Mission to Cure Macular Degeneration Blindness

     Morningstar· 4 days ago

     Twenty Million people in America (12% of the population over 40) have Macular Degeneration and Two Million people are blind from this disease and need a ...

2. • A Revolution In Gene Therapy Is Unfolding, Bringing Hope for Vision Loss

     Newswise· 2 days ago

     Two treatments for retinal diseases, invented by Neena Haider, PhD, that currently are in clinical trials run by Ocugen, represent a conceptually broad, new approach that ...

3. • 

     Home vision tests offer limited diagnostic accuracy for neovascular AMD

     Medical Xpress· 5 days ago

     No home-monitoring vision test has the diagnostic accuracy of hospital eye service follow-up clinics...

4. • 

     Can At-Home Vision Tests Detect Active Neovascular AMD?

     MedPage Today· 3 days ago

     The paper-based KeepSight Journal from the International Macular and Retinal Foundation, Genentech's...

5. • 

     Scientists find potential treatment target for leading cause of blindness

     Investing.com· 3 days ago

     New Delhi, May 2 (IANS) US scientists have found answers to why treatment for neovascular...

6. • ...Awarded $4 Million CIRM Grant to Support Clinical Trial of Adult RPESC-RPE-4W Therapy for Dry...

     Benzinga· 4 days ago

     Luxa Biotechnology (LuxaBio), a joint venture between Y2 Solution Co. Ltd, Seoul, South Korea and the Neural Stem Cell Institute (NSCI) in Rensselaer, New York, today announced receipt of a $4 million grant from the

7. • Obituaries in Topeka, KS | Topeka Capital-Journal

     The Topeka Capital-Journal· 2 days ago

     Margery Adeana McClacherty at the age of 96 peacefully passed away on April 27, 2024. Margery was born on September 10, 1927, in Bellingham, Washington; daughter of the late Guy William and ...

8. • Vision-Language Models for Feature Detection of Macular Diseases on Optical Coherence Tomography

     Journal of the American Medical Association· 3 days ago

     This cross-sectional study evaluates the performance of a vision-language model in performing ophthalmologic tasks related to interpretation of optical coherence tomography scans.

9. • Emmecell Completes Final Cell Therapy Dosing in U.S. Clinical Trial for Corneal Edema

     Digital Journal· 5 days ago

     Headquartered in Menlo Park, California, Emmecell is also the parent company...

10. • Stealth BioTherapeutics Announces Participation at Upcoming Ophthalmology Conferences

      WKBN 27 Youngstown· 3 days ago

      At the OIS Retina Innovation...